Clinicians Slam FDA Over Approval of Opioid Addiction Test

Researchers say a test meant to measure risk for opioid use disorder may cause harm. Their arguments are part of a larger debate about using genetic information to guide clinical care.

Related Keywords

United States ,California ,Maya Hambright ,Keri Donaldson ,Michaelt Abrams ,Alexander Hatoum ,Andrew Kolodny ,Us Centers For Disease ,Centers For Medicare ,Drug Administration ,National Institutes Of Health ,Brandeis University ,Washington University ,Medicaid Services ,Public Citizen Health Research Group ,Clinical Toxicology Devices Panel ,Public Citizen ,Health Research Group ,Medscape Medical ,Disease Control ,Medscape Medical News ,National Institutes ,New York ,Hudson Valley ,Pain Management ,Opioids ,Addiction ,Genetics ,Genetic Testing ,Genomics Genomic Medicine ,Overdose ,Rug Overdose ,Toxicology ,Toxicity ,Poisoning ,Toxins ,Washington Dc ,Washington District Of Columbia ,Medicare ,Narcotic ,Narcotic Use ,Washington ,Wound Management ,Wound Care ,Analgesia ,Analgesic ,Painkiller ,Cheek ,Children ,Child ,Childhood ,Ediatrics ,Kids ,Facial ,Fellowship ,Yellows ,